Biohit Oyj

€2.18As of Sun 8 Nov 2026, 12:00 UTC
HEL:BIOBVHealthcare
Country Finland
PE (Fwd) •••
TSR 10Y CAGR (9.59%)
Div yield —
ROE 21.42%
Medical Devices
Beta (5Y) 0.57
PE TTM 10.95
TSR TTM (29.22%)
Mkt cap €33.15M
ROIC 21.68%
SE Grade™
Value
Quality
Moat
Consensus
Reference
€2.17
(0.53%)
(94.43%)
Hold 9|0|9|10|7
4Q25
1Q26
2Q26
3Q26
Earnings per share€
0.03
0.04
0.04
0.04
(0.11%)
11.68%
24.18%
13.03%
Revenue€M
1.980
2.025
1.996
2.003
5.85%
3.70%
(2.67%)
(1.51%)
Peers (US$37.22M)
Cap (US$)
PE
79.89M
1,706x
51.52M
—
31.94M
—
37.30M
—
Capital
TTM
5Y
10Y
Leveragex
0.457
0.094
0.092
EBIT/Intx
1.068
0.122
0.124
Own earn%
(196.81)
(14.83)
(4.79)
Sh yield%
19.50
66.99
64.27
Owners
Insiders/Inst%
5.53
88.25
Short interest%
3.44
SBC / revenue%
1.66
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
17
Op margin range%
6–11
$1 testx
—
Incr. ROIC%
5